High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?
about
Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL.Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.
P2860
High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
High-dose methotrexate in Egyp ...... n plasma levels, what is next?
@en
type
label
High-dose methotrexate in Egyp ...... n plasma levels, what is next?
@en
prefLabel
High-dose methotrexate in Egyp ...... n plasma levels, what is next?
@en
P2093
P2860
P1476
High-dose methotrexate in Egyp ...... n plasma levels, what is next?
@en
P2093
Hala O El Mesallamy
Nadia M Hamdy
Nayera Hamdy
P2860
P2888
P304
P356
10.1007/S00432-014-1670-Y
P577
2014-04-10T00:00:00Z